Chargement Events

New treatment landscape with immunotherapy for advanced oesophageal cancer patients

11 octobre - 19h30 - 21h00

19:30
Opening
Prof. Dr. Eric Van Cutsem, UZ Leuven
 
 
19:35
Current treatment landscape with anti-PD-1 therapy for advanced esophageal cancer
Prof. Dr. Marc Van den Eynde, Cliniques Universitaires Saint-Luc, Brussels
 
20:00 GI immune related adverse events management with anti-PD-1 therapy
Prof. Dr. Marc Peeters, UZ Antwerpen
 
20:15
Pause
 
20:30 CPS testing in esophageal cancer
Dr. Vasiliki Siozopoulou, UZ Antwerpen
 
20h40 Q&A session
Moderator: Prof. Dr. Eric Van Cutsem, UZ Leuven
 
21:10 Closing

In collaboration with

  
MSD Belgium SRL / BV
Clos du Lynx, 5, Lynx Binnernhof – Bruxelles 1200 Brussel

Abbreviations:

UZ: Universitair Ziekenhuis
PD-1: Programmed death ligand 1
CPS: Combined Positive Score
Q&A: Questions and answers
 
 

BE-KEY-00665Date of last revision: 08/2021
$(document).ready(function() {$(‘#thechat’).html(‘